The nation of Zimbabwe has rejected a major American health deal worth $367m (272 million pounds) spanning five years because of the United States' demand for confidential data.
The decision came to light after a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
An official representative later stated that the US was demanding access to health data for scientific study and commercial gain while was unwilling to share the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged further negotiations to secure a agreement suitable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Implications
Zimbabwe's decision comes after a comparable case in Kenya, where a court suspended a related health funding agreement following legal challenges were raised about the safety of citizens' medical information.
After resuming office recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and responsibility.
As per statements, Sixteen African countries have to date signed these new health pacts, representing more than $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided extraordinary benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment via American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," he stated.
"Effectively, our country would supply the raw materials for medical research without any certainty that the resulting innovations would be accessible to our people if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further pointed out that the US's withdrawal from the global health body and its push of one-on-one deals were upending systems already established through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a nation provides its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued discussions with our American counterparts on how subsequent collaboration might be arranged in a way that respects the sovereignty and dignity of both nations."
Health Experts Reaction
A leading public health body stated it recognised the government's concerns, but recommended that negotiations should continue since a large portion of the nation's HIV programmes depended on international support.
"If specific concerns exist, including those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it said.
The halted deal emphasises the ongoing debate between accepting crucial international aid and protecting local interests in an increasingly data-driven world.